Retrospective Study
Copyright ©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 99602
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.99602
Table 3 The observation group is significantly lower than the control group in the incidence of adverse reactions, n (%)

Observation group (n = 66)
Control group (n = 62)
χ2
P value
Dizziness3 (4.55)4 (6.45)
Nausea1 (1.52)3 (4.84)
Insomnia1 (1.52)3 (4.84)
Eye swelling and pain0 (0.00)4 (6.45)
Total adverse reactions5 (7.58)14 (22.58)5.6940.017